Compound details
Necatorine
| Compound ID | CDAMM00949 |
|---|---|
| Common name | Necatorine | IUPAC name | 11-hydroxychromeno[5,6-c]cinnolin-2-one |
| Molecular formula | C15H8N2O3 |
| Retention time | 0.29 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 265.061 | Theoretical mz | 265.06 |
| Error | 1.98 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.1891 |
| Inchi key | WNQBVKOXDIYRFH-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C1OC=2C=C(O)C=3C(=NN=C4C=CC=CC43)C2C=C1 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Coumarins and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P21397 | MAOA | Monoamine oxidase A | T83875 | SEA |
| P11712 | CYP2C9 | Cytochrome P450 2C9 | T19244 | SwissTargetPrediction |
| Q5T7T8 | COX1 | Prostaglandin G/H synthase 1 | T60529 | SwissTargetPrediction |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SEA |
| P03372 | ESR1 | Estrogen receptor alpha | T02506 | SEA |
| P08236 | GUSB | Beta-glucuronidase | T96413 | SEA |
| P47989 | XDH | Xanthine dehydrogenase | T40954 | SEA |
| Q16549 | PCSK7 | Subtilisin/kexin type 7 | T33211 | SEA |
| P22001 | KCNA3 | Voltage-gated potassium channel subunit Kv1.3 | T76914 | SEA |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| Q9UNI1 | CELA1 | Elastase 1 | T22839 | SEA |
| Q92952 | KCNN1 | Small conductance calcium-activated potassium channel protein 1 | T11911 | SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SEA |
| Q13332 | PTPRS | Receptor-type tyrosine-protein phosphatase S | T10147 | SEA |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| Q9H2S1 | KCNN2 | Small conductance calcium-activated potassium channel protein 2 | T86271 | SEA |
| P16220 | CREB1 | Cyclic AMP-responsive element-binding protein | T92098 | SEA |
| Q15717 | ELAVL1 | ELAV-like protein 1 | T78349 | SEA |
| Q96HK3 | CALM | Calmodulin | T39610 | SEA |
| Q09470 | KCNA1 | Voltage-gated potassium channel Kv1.1 | T85272 | SEA |
| Q96RP8 | KCNA7 | Voltage-gated potassium channel Kv1.7 | T84737 | SEA |
| P22459 | KCNA4 | Voltage-gated A-type potassium channel | T15665 | SEA |
| P16389 | KCNA2 | Voltage-gated potassium channel Kv1.2 | T19492 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T83875 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P21397 | MAOA |
| T83875 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21397 | MAOA |
| T19244 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P11712 | CYP2C9 |
| T60529 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | Q5T7T8 | COX1 |
| T60529 | DI0145 | Female pelvic pain | [ICD-11: GA34] | Q5T7T8 | COX1 |
| T60529 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q5T7T8 | COX1 |
| T60529 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | Q5T7T8 | COX1 |
| T60529 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q5T7T8 | COX1 |
| T60529 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q5T7T8 | COX1 |
| T60529 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q5T7T8 | COX1 |
| T60529 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q5T7T8 | COX1 |
| T60529 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q5T7T8 | COX1 |
| T60529 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | Q5T7T8 | COX1 |
| T60529 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | Q5T7T8 | COX1 |
| T60529 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | Q5T7T8 | COX1 |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T02506 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P03372 | ESR1 |
| T96413 | DI0242 | Lysosomal disease | [ICD-11: 5C56] | P08236 | GUSB |
| T40954 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | P47989 | XDH |
| T40954 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P47989 | XDH |
| T76914 | DI0198 | Idiopathic inflammatory myopathy | [ICD-11: 4A41] | P22001 | KCNA3 |
| T76914 | DI0351 | Psoriasis | [ICD-11: EA90] | P22001 | KCNA3 |
| T76914 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P22001 | KCNA3 |
| T22839 | DI0024 | Alpha-1-antitrypsin deficiency | [ICD-11: 5C5A] | Q9UNI1 | CELA1 |
| T22839 | DI0065 | Bronchitis | [ICD-11: CA20] | Q9UNI1 | CELA1 |
| T11911 | DI0285 | Myelopathy | [ICD-11: 8B42] | Q92952 | KCNN1 |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |
| T10147 | DI0057 | Bone paget disease | [ICD-11: FB85] | Q13332 | PTPRS |
| T86271 | DI0285 | Myelopathy | [ICD-11: 8B42] | Q9H2S1 | KCNN2 |
| T39610 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | Q96HK3 | CALM |
| T39610 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q96HK3 | CALM |
| T39610 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q96HK3 | CALM |